Display options
Cite
Vostrov AA, Taheny MJ, Izkhakov N, et al. A nuclear factor-binding domain in the 5'-untranslated region of the amyloid precursor protein promoter: implications for the regulation of gene expression. BMC Res Notes. 2010;3:4doi: 10.1186/1756-0500-3-4.
Vostrov, A. A., Taheny, M. J., Izkhakov, N., & Quitschke, W. W. (2010). A nuclear factor-binding domain in the 5'-untranslated region of the amyloid precursor protein promoter: implications for the regulation of gene expression. BMC research notes, 34. https://doi.org/10.1186/1756-0500-3-4
Vostrov, Alexander A, et al. "A nuclear factor-binding domain in the 5'-untranslated region of the amyloid precursor protein promoter: implications for the regulation of gene expression." BMC research notes vol. 3 (2010): 4. doi: https://doi.org/10.1186/1756-0500-3-4
Vostrov AA, Taheny MJ, Izkhakov N, Quitschke WW. A nuclear factor-binding domain in the 5'-untranslated region of the amyloid precursor protein promoter: implications for the regulation of gene expression. BMC Res Notes. 2010 Jan 12;3:4. doi: 10.1186/1756-0500-3-4. PMID: 20205906; PMCID: PMC2828463.
Copy Download .nbib Format: NLM
Share it on

BMC Res Notes. 2010 Jan 12;3:4. doi: 10.1186/1756-0500-3-4.

A nuclear factor-binding domain in the 5'-untranslated region of the amyloid precursor protein promoter: implications for the regulation of gene expression.

BMC research notes

Alexander A Vostrov, Michael J Taheny, Nerik Izkhakov, Wolfgang W Quitschke

Affiliations

  1. Department of Psychiatry and Behavioral Science, State University of New York at Stony Brook, Stony Brook, NY 11794-8101, USA.

PMID: 20205906 PMCID: PMC2828463 DOI: 10.1186/1756-0500-3-4

Abstract

BACKGROUND: The extracellular deposition of aggregated amyloid beta-protein is a neuropathological manifestation of Alzheimer disease and Down syndrome. The Amyloid beta-protein is derived from a group of larger differentially spliced proteins, the amyloid protein precursors (APP). Data suggests that the level of APP gene expression could contribute to the pathological processes leading to amyloid depositions.

FINDINGS: The 5' untranslated region (UTR) of the APP gene, encompassing 147 base pairs between the transcriptional (+1) and the translational start site, was examined for its role in APP expression. Deletions close to the transcriptional start site reduced expression from the APP promoter in part by transcriptional mechanisms. However, deletions between position +50 and +104 had no effect on transcriptional activity while significantly reducing overall expression from the promoter. A nuclear factor-binding domain designated as DAPB was identified between position +72 and +115 of the 5'-APP-UTR. The binding-recognition sequence was localized between position +96 and +105. The same mutations that eliminated factor-binding also reduced expression from the APP promoter while having no effect on in vitro transcription or the RNA levels transcribed from transfected constructs.

CONCLUSIONS: A nuclear factor-binding domain designated as DAPB was identified in the 5'-UTR of the APP gene. Elimination of factor-binding correlated with an overall decline in expression from the APP promoter while in vitro transcription and the total amount of in vivo transcribed RNA remained unaffected. This suggests that the binding-factor may have a function in post-transcriptional regulation, including nuclear export of mRNA.

References

  1. J Biol Chem. 1998 Nov 13;273(46):30366-71 - PubMed
  2. J Biol Chem. 2002 Nov 22;277(47):45518-28 - PubMed
  3. Nature. 1987 Feb 19-25;325(6106):733-6 - PubMed
  4. Genome Res. 2009 Aug;19(8):1471-9 - PubMed
  5. Proc Natl Acad Sci U S A. 1985 Jun;82(12):4245-9 - PubMed
  6. Nucleic Acids Res. 2008 Dec;36(21):6835-47 - PubMed
  7. Biochem Biophys Res Commun. 1984 May 16;120(3):885-90 - PubMed
  8. Acta Neuropathol. 1990;80(3):318-27 - PubMed
  9. Biochim Biophys Acta. 2009 Jul;1790(7):615-28 - PubMed
  10. Mol Cell Biol. 2005 Nov;25(21):9674-86 - PubMed
  11. Nat Genet. 2006 Jan;38(1):24-6 - PubMed
  12. Neuron. 2006 Jul 6;51(1):29-42 - PubMed
  13. Proc Natl Acad Sci U S A. 1985 Jan;82(2):488-92 - PubMed
  14. J Mol Neurosci. 2003;20(3):267-75 - PubMed
  15. J Mol Neurosci. 2002 Aug-Oct;19(1-2):77-82 - PubMed
  16. Am J Hum Genet. 2006 Jun;78(6):936-46 - PubMed
  17. Neuron. 1988 Oct;1(8):669-77 - PubMed
  18. J Biol Chem. 1996 Sep 6;271(36):22231-9 - PubMed
  19. BMC Res Notes. 2009 Sep 09;2:178 - PubMed
  20. J Biol Chem. 1999 Mar 5;274(10):6421-31 - PubMed
  21. Exp Mol Med. 2002 Sep 30;34(4):259-64 - PubMed
  22. J Biol Chem. 1994 Aug 19;269(33):21229-33 - PubMed
  23. Physiol Rev. 2001 Jul;81(3):1097-142 - PubMed
  24. Genes Dev. 2004 Jul 1;18(13):1606-17 - PubMed
  25. FASEB J. 2005 Apr;19(6):653-5 - PubMed
  26. J Biol Chem. 1992 Aug 25;267(24):17362-8 - PubMed
  27. Mol Endocrinol. 2004 Apr;18(4):863-73 - PubMed

Publication Types